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Asymptomatic spinal cord lesions are found in 30-50% of people with a clinically 
isolated syndrome (CIS).1-3 Spinal cord MRI can assist in the diagnosis of multiple 
sclerosis (MS) in CIS patients4, particularly in the subgroup of patients without 
evidence of dissemination in space on brain MRI at the time of presentation.2, 3 
Because typical short-segment spinal cord lesions are a relatively specific finding to 
MS, spinal cord MRI may also assist in differential diagnosis, and may be helpful in 
avoiding misdiagnosis.5  
 
Two recent studies have suggested that spinal cord lesions in CIS patients may not 
only be helpful in making diagnosis of MS, but may also provide additional 
prognostic information.1, 2 In a study involving 131 CIS patients with a non-spinal CIS 
who had brain and spinal MRI within 3 months of presentation, asymptomatic spinal 
cord lesions were the strongest MRI predictor of physical disability after 5 years.1 
Similarly, in another study of 207 prospectively recruited CIS patients with brain and 
spinal imaging with 3 months of disease onset, spinal cord lesions were associated 
with an increased risk of reaching Expanded Disability Status Scale (EDSS) 3 or 
more over a follow-up period of almost 3 years, even after adjusting for brain MRI 
findings and other relevant prognostic markers.2 The prognostic value of spinal cord 
lesions was highest in patients with a non-spinal CIS.2 Collectively these studies 
suggest that asymptomatic spinal cord lesions seen at the time of presentation with 
CIS are associated with an increased risk of physical disability, at least in the short to 
medium term, and may provide much needed prognostic information to help counsel 
patients about their risk of future disability.1, 2  
 
In this issue of Multiple Sclerosis Journal Dekker and colleagues investigate the 
impact of asymptomatic spinal cord lesions in a cohort of patients recruited within 12 
months presentation with CIS.6 More than half of the patients already had a 
diagnosis of MS using the McDonald 2010 criteria at the time of study entry. MRI 
scans of the brain and spinal cord were obtained at “baseline” (within 12 months of 
disease onset) and the patients were followed up prospectively for the development 
of disability. Over a median follow-up period of 6 years no difference was seen in the 
time to reaching EDSS 3 and 6, or confirmed worsening in timed 25-foot walk and 9-
hole peg test speeds in patients with and without asymptomatic spinal cord lesions. 
The authors conclude that the prognostic significance of asymptomatic spinal cord 
lesions in patients with CIS and early MS is uncertain. 
 
The author’s findings do contrast with other recent work1, 2 and this might reflect 
differences in the patient population studied, the analytical approach, or both. In the 
current study over 96% of patients had an abnormal brain MRI at presentation, 
compared with 65-80% in other studies.1, 2 The higher proportion of patients with 
normal brain MRI in previous studies might have accentuated the prognostic value of 
asymptomatic spinal lesions: this group of patients are at much lower risk for the 
development of MS and disability7, and asymptomatic spinal cord lesions are 
uncommon in patients with a normal brain MRI.8 The authors approach to the 
analyses might also potentially account for the negative results. In their main 
analyses Dekker and colleagues compare the time to disability worsening in patients 
with asymptomatic spinal cord lesions at study entry to a comparator group without 
asymptomatic spinal cord lesions. The comparator group was very heterogeneous 
and included: (1) patients with a non-spinal CIS with normal spinal MRI; (2) patients 
with spinal cord syndromes with a normal spinal MRI; and (3) patients with spinal 
cord syndromes with an abnormal spinal MRI. In total more than three quarters of 
the patients in the comparator group presented with a spinal cord syndrome, had a 
spinal cord relapse prior to study entry, or both. Therefore in reality the authors 
compare the time to disability worsening in patients with CIS or early MS with 
(predominantly) symptomatic spinal cord lesions to a group with asymptomatic spinal 
cord lesions. The fact that there was no difference in the time to disability worsening 
study might suggest that early spinal cord damage in relapse-onset MS, whether 
symptomatic or asymptomatic, may have similar functional consequences and carry 
a similar risk of future disability.  
 
Whether routine spinal cord MRI should be done in all patients with CIS and early 
MS is controversial.9 Current European and North American guidelines only 
recommend spinal cord imaging in selected patient groups.10, 11 The additional 
diagnostic value of spinal cord MRI is known to be modest2, 3, at least for providing 
evidence of dissemination in space in patients with typical clinical presentations 
suggestive of MS. Although other recent work has suggested a prognostic role for 
spinal cord imaging in patients with CIS and early MS1, 2, the findings of Dekker and 
colleagues will add to the ongoing uncertainty over the diagnostic and prognostic 
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